The examination of top-cited studies is a useful method for identify and monitoring outstanding scientific research. The objective of this study was to identify and analyse the characteristics of the top 100 cited research studies on tuberculosis (TB) based on the Web of Knowledge. Overall, the top 100 cited studies were cited between 366 and 4443 times, and were published between 1995 and 2010, with the largest number of publications in 2003 and in 1995. Four studies were attributed to a single author and 10 to two authors; the number of authors exceeded six in 50 studies. Nine authors had more than one study as the first author and 18 authors had more than one study as the corresponding author. The United States contributed the largest number of studies, followed by the United Kingdom and France. The institutions with the largest number of articles were the Institut National de la Santé et de la Recherche Médicale in France and the University of California in the United States. The studies appeared in 35 journals, with 11 published in Science, followed by PNAS and NEJM. The majority of TB articles have been published in those medical journals with the highest impact factors, and are from the most industrialised countries. K E Y W O R D S : tuberculosis; citation; top-cited studies THE MOST WIDELY USED METHOD for evaluating the academic importance of a study in a specific area of knowledge is determining how many times the study has been cited by other researchers. 1 It is well known that the number of citations for a study might express the potential of the study for clinical practice, discussion, controversy or further research. 2 Citations analysis has become a useful method for assessing the quality, trend and future of some research fields. 1, 3, 4 Although citations analyses from the Science Citation Index Expanded TM of the Web of Science TM (Thomson Reuters, Philadelphia, PA, USA) in recent years have enabled researchers to assess the importance of research in areas such as obstetrics and gynaecology, emergency medicine, urology and orthopedics, 2,5-7 many new studies, such as research on tuberculosis (TB) studies, remain to be conducted.
TB is one of the most common causes of death due to an infectious disease, [8] [9] [10] [11] [12] and is an important subject of medical research. [13] [14] [15] Studies related to pathology, physiopathology, diagnosis, manifestations, treatment, prognosis, prevention, epidemiology and patient education are the most widely studied issues in TB. [16] [17] [18] [19] [20] To our knowledge, no citation analysis has been published in the field of TB.
The objective of the present study was to use the bibliometric resources of the Web of Science to identify the 100 most cited studies published on TB and to analyse their principal characteristics. 21 This is, to our knowledge, the first bibliometric analysis of TB studies.
METHODS
Two independent reviewers (LMC and TYX) searched TB studies using the cited reference search tool of the Web of Knowledge in the Web of Science's core collection. A topic search with the terms 'tuberculo*' or 'tuberculosis' or 'TB' was conducted, and search results sorted by number of citations. The following inclusion criteria were used: 1) studies that reported mainly on TB disease or on Mycobacterium tuberculosis; and 2) studies that were articles, reviews, editorials or research letters. The exclusion criteria were as follows: 1) studies that mentioned the word 'tuberculosis' but did not deal with TB; and 2) abstracts, corrigenda/errata, correspondence. Any disagreements were resolved by discussion or decided by the third author (YQL).
We identified the 100 top cited studies by number of citations on 10 January 2015. The following information was extracted for each study: number of citations, first author, corresponding author, number of authors, publication name, year, country of origin and number of pages. Country of origin was determined on the basis of the country of the first author.
RESULTS

Main characteristics of the included studies
The Appendix Table* shows the characteristics of the top 100 cited studies in TB research in descending order. The number of citations varied between 366 and 4443, with a total of 62 801. All of the first 11 studies exceeded 1000 citations each, and the first 46 had more than 500 citations each. It is possible to comment only on three of the most relevant articles here. The most cited study (4443 citations) was a research study about the complete genome sequence of M. tuberculosis, published in 1998 by Cole et al. in Nature. 22 The second study (1881 citations), on TB associated with infliximab, was published in 2001 by Keane et al in NEJM. 23 The study reported that as active TB could develop soon after the initiation of treatment with infliximab, physicians could use the drug to screen patients for latent tuberculous infection or TB disease. The third most cited study was a report published in JAMA in 1999 by Dye et al. on the global burden of TB. 24 Author distribution Four articles were attributed to a single author and 10 to two authors; the number of authors exceeded six in 50 studies. Authors with more than one study as the first author or corresponding author have been listed in Table 1 . Nine authors had more than one study as the first author, and 18 had more than one study as the corresponding author. The author with the largest number of studies as corresponding author was Modlin (n ¼ 4).
Country distribution
The country of the corresponding author was used to analyse country contributions on TB (Table 2 ). Briefly, the top 100 cited studies were from 13 countries (Argentina, Belgium, Canada, Denmark, the United Kingdom, France, Germany, Japan, the Netherlands, South Africa, Spain, Switzerland and the United States) and one international organization (World Health Organization [WHO] ). The country with the most top cited studies was the United States, with 58 studies, followed by the United Kingdom with 11 and France with 6. The country with the most citations was the United States, with 33 673 citations, followed by the United Kingdom, with 9498 citations. The countries with most citations on average were the United Kingdom, with 864, followed by Argentina, with 828.
Institutional distribution
To analyse contributions from institutions, those with at least two studies based on the first address of the corresponding author were examined (Table 3) . Eighteen institutions with more than two studies were included. The institutions with the largest number of articles were the Institut National de la Santé et de la Recherche Médicale (INSERM) (n ¼ 6) in Paris, France, and the University of California (n ¼ 6) in the United States, followed by the University of Oxford, Oxford, UK (n ¼ 5), the WHO, Geneva, Switzerland (n ¼ 5), and Cornell University, Ithaca, NY, USA (n ¼ 5).
Distribution by year of publication
The distribution by year of publication of the top 100 cited studies is shown in Table 4 
Distribution by journal
The top 100 studies were published in 35 journals ( Table 5 ). The journal with the largest number of articles cited was Science (n ¼ 11), followed by PNAS (n ¼ 10), the NEJM (n ¼ 8) and the Lancet (n ¼ 8). The journal with the most citations was Science, with 7107, followed by Nature, with 6388. The journal with the highest average number of citations per article was JAMA, with 1481 citations, followed by Nature, with 1352.
DISCUSSION
TB is historically the greatest killer worldwide due to an infectious agent. 11, 12, 25 Although there has been considerable progress in anti-tuberculosis treatment,
8.6 million people were estimated to have TB and 1.3 million died from the disease in 2012. Although research on TB has increased each year, no bibliometric studies have been conducted on TB research.
We performed the present study to determine the top 100 cited studies in TB research. The 100 top-cited studies were cited 366-4443 times. Compared to citations in other medical fields, this occupies a middle position: in general surgery the number of citations for top-cited studies ranged from 278 to 1013, 26 compared to 781-26 578 for psychiatry. 27 The difference in the number of citations of the top 100 cited studies in each specialty reflects its research history and the number of researchers working in that field. 28 Studies with more than 100 citations are considered 'classic' studies that consti- Top-cited TB researches tute historical reference points in the development of a specific area. 29 In the present study, the article that occupied position 100 in the rankings had 366 citations, suggesting that a large number of classic studies had not been analysed in the present study.
Our results show that most of the top 100 cited TB research studies were published between 1995 and 2010. Scientific studies are generally cited 1-2 years after publication, reaching a maximum citation rate 7-10 years after publication. An interval of 10-20 years is needed for maximum recognition of prominent articles in a field. 28, 29 This would explain why recent articles were cited rarely and why most of the studies included in our list were published in the 1990s.
It is also well known that the principal journals attract articles with a high citation rate, 28 ,29 which in turn helps to maintain the impact factor of these journals; this accounts for the clustering of articles in a small number of journals, particularly those that frequently publish studies on TB. In the present study, 48 studies were published in journals with an impact factor of .20, including the Annual Review of Biochemistry, the Annual Review of Immunology, Cell, JAMA, The Lancet, Nature Immunology, Nature Medicine, Nature Reviews Immunology, Nature Reviews Molecular Cell Biology, the NEJM and Science. Our results confirm the close relation- ship between citations and impact, and that the most cited studies are often published in journals that top the impact factor list, which also helps maintain the high impact factor of these journals. In line with other, similar studies, more than half of the publications originated from the United States, followed by the United Kingdom. Our results reflect the large number of TB researchers in the United States and the considerable scientific output in the United States, which dominates the field of TB publications.
Although the world's highest TB burdens are in low-and middle-income countries, most of the highly cited papers are from high-income countries. The authors tend to originate from high-income countries even though the actual research was conducted in low-income, high-burden countries, such as Gandhi et al. 30 and Bellamy et al. 31 It is therefore necessary to strengthen TB research capacity in low-and middleincome countries, especially in BRICS (Brazil, Russia, India, China, South Africa) countries, which account for a substantial proportion of the global TB burden and are now making large investments in science and research.
There are several limitations of this study. First, it was based on the Web of Knowledge database alone; the Web of Science does not index all journals and we may have missed journals that figure in other databases such as Scopus and Google Scholar. Our results should therefore be used with caution. Second, as we only analysed the corresponding and first authors' contributions in our analysis, we may have missed important contributions from other authors; future studies should focus on this issue.
In conclusion, this is the first bibliometric assessment of TB literature. Interest in TB as a serious clinical problem continues to grow. Research published in high-impact journals and from industrialised countries is most likely to be cited in published TB research. 
